{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:28:57Z","timestamp":1786987737598,"version":"build-2736575974"},"reference-count":127,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["mdconsult.com","theclinics.com","derm.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.det.2014.09.004","type":"journal-article","created":{"date-parts":[[2014,11,18]],"date-time":"2014-11-18T04:45:40Z","timestamp":1416285940000},"page":"41-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":144,"title":["Psoriasis Is a Systemic Disease with Multiple Cardiovascular and Metabolic Comorbidities"],"prefix":"10.1016","volume":"33","author":[{"given":"Caitriona","family":"Ryan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.det.2014.09.004_bib1","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/archderm.143.12.1493","article-title":"The risk of mortality in patients with psoriasis: results from a population-based study","volume":"143","author":"Gelfand","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib2","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","article-title":"Risk of myocardial infarction in patients with psoriasis","volume":"296","author":"Gelfand","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.det.2014.09.004_bib3","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0190-9622(95)91336-X","article-title":"Disease concomitance in psoriasis","volume":"32","author":"Henseler","year":"1995","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib4","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1056\/NEJM197304262881715","article-title":"Occlusive vascular disease in psoriatic patients","volume":"288","author":"McDonald","year":"1973","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.det.2014.09.004_bib5","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1365-2133.2008.08707.x","article-title":"Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis","volume":"159","author":"Kaye","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1023\/B:EJEP.0000020447.59150.f9","article-title":"Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients","volume":"19","author":"Mallbris","year":"2004","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.det.2014.09.004_bib7","doi-asserted-by":"crossref","first-page":"e000062","DOI":"10.1161\/JAHA.113.000062","article-title":"Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies","volume":"2","author":"Armstrong","year":"2013","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.det.2014.09.004_bib8","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-2133.2010.09941.x","article-title":"Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the UK","volume":"163","author":"Abuabara","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib9","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/jid.2009.321","article-title":"Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohort","volume":"130","author":"Wakkee","year":"2010","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib10","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/jid.2010.399","article-title":"Very severe psoriasis is associated with increased noncardiovascular mortality but not with increased cardiovascular risk","volume":"131","author":"Stern","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib11","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/jid.2011.32","article-title":"Psoriasis and cardiovascular risk: strength in numbers, part II","volume":"131","author":"Gelfand","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000182256","article-title":"Chronic plaque psoriasis is associated with increased arterial stiffness","volume":"218","author":"Gisondi","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.det.2014.09.004_bib13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2133.2006.07562.x","article-title":"Psoriasis: a possible risk factor for development of coronary artery calcification","volume":"156","author":"Ludwig","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000354726","article-title":"Epicardial fat thickness is independently associated with psoriasis","volume":"228","author":"Akyildiz","year":"2014","journal-title":"Dermatology"},{"key":"10.1016\/j.det.2014.09.004_bib15","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/HJH.0b013e32835bcce1","article-title":"The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies","volume":"31","author":"Armstrong","year":"2013","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.det.2014.09.004_bib16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/2013.jamadermatol.406","article-title":"Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis","volume":"149","author":"Armstrong","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib17","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1001\/archinte.167.15.1670","article-title":"Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II","volume":"167","author":"Setty","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.det.2014.09.004_bib18","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jaad.2005.11.1079","article-title":"Psoriasis is associated with lipid abnormalities at the onset of skin disease","volume":"54","author":"Mallbris","year":"2006","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib19","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1001\/archderm.141.12.1527","article-title":"Impact of obesity and smoking on psoriasis presentation and management","volume":"141","author":"Herron","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib20","unstructured":"Available at: http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00879944?term=pediatric+psoriasis&rank=3. Accesssed 29 June, 2014."},{"key":"10.1016\/j.det.2014.09.004_bib21","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1001\/jamadermatol.2013.1078","article-title":"Association of pediatric psoriasis severity with excess and central adiposity: an international cross-sectional study","volume":"149","author":"Paller","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib22","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"Eckel","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.det.2014.09.004_bib23","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00403-006-0703-z","article-title":"Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis","volume":"298","author":"Sommer","year":"2006","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.det.2014.09.004_bib24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","article-title":"Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.det.2014.09.004_bib25","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/jid.2011.365","article-title":"Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom","volume":"132","author":"Langan","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib26","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/pde.12218","article-title":"Prevalence of the metabolic syndrome in children with psoriatic disease","volume":"30","author":"Goldminz","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib27","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/art.38227","article-title":"Hypercholesterolemia and risk of incident psoriasis and psoriatic arthritis in US women","volume":"66","author":"Wu","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.det.2014.09.004_bib28","first-page":"285","article-title":"Aortic vascular inflammation in psoriasis is associated with HDL particle size and concentration: a pilot study","volume":"2","author":"Yu","year":"2012","journal-title":"Am J Cardiovasc Dis"},{"key":"10.1016\/j.det.2014.09.004_bib29","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.atherosclerosis.2012.06.068","article-title":"Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis","volume":"224","author":"Mehta","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.det.2014.09.004_bib30","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1194\/jlr.M027367","article-title":"Psoriasis alters HDL composition and cholesterol efflux capacity","volume":"53","author":"Holzer","year":"2012","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.det.2014.09.004_bib31","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/jid.2013.359","article-title":"Anti-psoriatic therapy recovers high-density lipoprotein composition and function","volume":"134","author":"Holzer","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib32","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1540-9740.2005.03716.x","article-title":"Smoking and psoriasis","volume":"4","author":"Behnam","year":"2005","journal-title":"Skinmed"},{"key":"10.1016\/j.det.2014.09.004_bib33","doi-asserted-by":"crossref","first-page":"492","DOI":"10.2340\/00015555-0711","article-title":"Excessive body weight and smoking associates with a high risk of onset of plaque psoriasis","volume":"89","author":"Wolk","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.det.2014.09.004_bib34","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1001\/archderm.135.12.1490","article-title":"Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis","volume":"135","author":"Poikolainen","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib35","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1365-2133.2011.10345.x","article-title":"Alcohol misuse in patients with psoriasis: identification and relationship to disease severity and psychological distress","volume":"164","author":"McAleer","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib36","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/bjd.12670","article-title":"Psoriasis and smoking: a systematic review and meta-analysis","volume":"170","author":"Armstrong","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib37","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1600-0625.2010.01224.x","article-title":"Tobacco smoke is related to Th17 generation with clinical implications for psoriasis patients","volume":"20","author":"Torii","year":"2011","journal-title":"Exp Dermatol"},{"issue":"3","key":"10.1016\/j.det.2014.09.004_bib38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/HCR.0000000000000042","article-title":"An expanding knowledge of the mechanisms and effects of alcohol consumption on cardiovascular disease","volume":"34","author":"Matsumoto","year":"2014","journal-title":"J\u00a0Cardiopulm Rehabil Prev"},{"key":"10.1016\/j.det.2014.09.004_bib39","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1365-2133.2008.08749.x","article-title":"Psoriasis and chronic obstructive pulmonary disease: a case-control study","volume":"159","author":"Dreiher","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2230.2010.03877.x","article-title":"Homocysteine status and cardiovascular risk factors in patients with psoriasis: a case-control study","volume":"36","author":"Tobin","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib41","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.genhosppsych.2006.12.004","article-title":"Understanding the relationship between objective disease severity, psoriatic symptoms, illness-related stress, health-related quality of life and depressive symptoms in patients with psoriasis - a structural equations modeling approach","volume":"29","author":"Schmitt","year":"2007","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.det.2014.09.004_bib42","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/1741-7015-11-250","article-title":"The contribution of major depression to the global burden of ischemic heart disease: a comparative risk assessment","volume":"11","author":"Charlson","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.det.2014.09.004_bib43","first-page":"179","article-title":"Psoriasis and cardiovascular disorders","volume":"147","author":"Ryan","year":"2012","journal-title":"G\u00a0Ital Dermatol Venereol"},{"key":"10.1016\/j.det.2014.09.004_bib44","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/jid.2010.103","article-title":"Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions","volume":"130","author":"Davidovici","year":"2010","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib45","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1055\/s-0029-1222610","article-title":"Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors","volume":"35","author":"Gisondi","year":"2009","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.det.2014.09.004_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdermsci.2011.04.007","article-title":"Angiogenesis and oxidative stress: common mechanisms linking psoriasis with atherosclerosis","volume":"63","author":"Armstrong","year":"2011","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.det.2014.09.004_bib47","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1600-0625.2011.01261.x","article-title":"The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity","volume":"20","author":"Boehncke","year":"2011","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib48","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ni.2001","article-title":"The immune system in atherosclerosis","volume":"12","author":"Hansson","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.det.2014.09.004_bib49","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.det.2014.09.004_bib50","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/01.mca.0000236288.94553.b4","article-title":"Role of interleukin-17 and interleukin-17-induced cytokines interleukin-6 and interleukin-8 in unstable coronary artery disease","volume":"17","author":"Hashmi","year":"2006","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.det.2014.09.004_bib51","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3109\/14017431.2010.491123","article-title":"Increased Th17 cells in coronary artery disease are associated with neutrophilic inflammation","volume":"45","author":"Wang","year":"2011","journal-title":"Scand Cardiovasc J"},{"key":"10.1016\/j.det.2014.09.004_bib52","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/eurheartj\/ehq084","article-title":"Cellular actors, Toll-like receptors, and local cytokine profile in acute coronary syndromes","volume":"31","author":"Wyss","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.det.2014.09.004_bib53","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clim.2008.01.009","article-title":"The Th17\/Treg imbalance in patients with acute coronary syndrome","volume":"127","author":"Cheng","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.det.2014.09.004_bib54","first-page":"325","article-title":"Emerging role of IL-17 in atherosclerosis","volume":"2","author":"Chen","year":"2010","journal-title":"J\u00a0Innate Immun"},{"key":"10.1016\/j.det.2014.09.004_bib55","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cyto.2009.09.007","article-title":"The Th17\/Treg functional imbalance during atherogenesis in ApoE(-\/-) mice","volume":"49","author":"Xie","year":"2010","journal-title":"Cytokine"},{"key":"10.1016\/j.det.2014.09.004_bib56","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.108.827618","article-title":"Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells","volume":"119","author":"Eid","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.det.2014.09.004_bib57","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1084\/jem.20090545","article-title":"Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis","volume":"206","author":"Taleb","year":"2009","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.det.2014.09.004_bib58","doi-asserted-by":"crossref","first-page":"H2101","DOI":"10.1152\/ajpheart.00125.2007","article-title":"Endothelial STAT3 plays a critical role in generalized myocardial proinflammatory and proapoptotic signaling","volume":"293","author":"Wang","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.det.2014.09.004_bib59","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/1479-5876-11-194","article-title":"Modulation of cardiometabolic pathways in skin and serum from patients with psoriasis","volume":"11","author":"Mehta","year":"2013","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.det.2014.09.004_bib60","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1210\/jc.2008-1613","article-title":"Adipocytokines and the metabolic complications of obesity","volume":"93","author":"Rasouli","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.det.2014.09.004_bib61","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/archderm.144.12.1571","article-title":"Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome","volume":"144","author":"Chen","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib62","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0140-6736(03)12255-6","article-title":"Adiponectin and protection against type 2 diabetes mellitus","volume":"361","author":"Spranger","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.det.2014.09.004_bib63","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0026-0495(03)00313-5","article-title":"Low adipocyte-derived plasma protein adiponectin concentrations are associated with the metabolic syndrome and small dense low-density lipoprotein particles: atherosclerosis and insulin resistance study","volume":"52","author":"Hulthe","year":"2003","journal-title":"Metabolism"},{"key":"10.1016\/j.det.2014.09.004_bib64","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","article-title":"Positional cloning of the mouse obese gene and its human homologue","volume":"372","author":"Zhang","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.det.2014.09.004_bib65","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.1074\/jbc.272.10.6093","article-title":"The leptin receptor","volume":"272","author":"Tartaglia","year":"1997","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.det.2014.09.004_bib66","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1161\/01.RES.83.10.1059","article-title":"Leptin, the product of Ob gene, promotes angiogenesis","volume":"83","author":"Bouloumi\u00e9","year":"1998","journal-title":"Circ Res"},{"key":"10.1016\/j.det.2014.09.004_bib67","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1172\/JCI9148","article-title":"Leptin enhances wound re-epithelialization and constitutes a direct function of leptin in skin repair","volume":"106","author":"Frank","year":"2000","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.det.2014.09.004_bib68","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1365-2133.2008.08742.x","article-title":"Serum leptin levels, skin leptin and leptin receptor expression in psoriasis","volume":"159","author":"Cerman","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib69","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.mehy.2005.11.050","article-title":"Chronic inflammation in psoriasis and obesity: implications for therapy","volume":"67","author":"Hamminga","year":"2006","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.det.2014.09.004_bib70","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1079\/PNS2004406","article-title":"The biology of obesity","volume":"64","author":"Trayhurn","year":"2005","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.det.2014.09.004_bib71","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1365-2133.2008.08456.x","article-title":"Psoriasis is associated with increased levels of serum leptin","volume":"158","author":"Wang","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib72","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.bbrc.2004.02.130","article-title":"Adiponectin differentially regulates cytokines in porcine macrophages","volume":"316","author":"Wulster-Radcliffe","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.det.2014.09.004_bib73","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1042\/CS20050182","article-title":"Adiponectin: a key adipocytokine in metabolic syndrome","volume":"110","author":"Okamoto","year":"2006","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.det.2014.09.004_bib74","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/j.1365-2133.2008.08759.x","article-title":"Clear differences in adiponectin level and glutathione redox status revealed in obese and normal-weight patients with psoriasis","volume":"159","author":"Kaur","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib75","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jdermsci.2009.05.008","article-title":"Circulating levels of adiponectin, oxidized LDL and C-reactive protein in Portuguese patients with psoriasis vulgaris, according to body mass index, severity and duration of the disease","volume":"55","author":"Coimbra","year":"2009","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.det.2014.09.004_bib76","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jdermsci.2009.02.009","article-title":"Serum high molecular weight adiponectin levels are decreased in psoriasis patients","volume":"55","author":"Shibata","year":"2009","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.det.2014.09.004_bib77","first-page":"1207","article-title":"Plasma adiponectin and leptin levels in Japanese patients with psoriasis","volume":"159","author":"Takahashi","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib78","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/ced.12250","article-title":"Psoriasis is associated with decreased plasma adiponectin levels independently of cardiometabolic risk factors","volume":"39","author":"Li","year":"2014","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib79","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s00125-006-0173-z","article-title":"Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin","volume":"49","author":"Curat","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.det.2014.09.004_bib80","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.clim.2009.07.013","article-title":"The role of resistin as a regulator of inflammation: implications for various human pathologies","volume":"133","author":"Filkov\u00e1","year":"2009","journal-title":"Clin Immunol"},{"key":"10.1016\/j.det.2014.09.004_bib81","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1253\/circj.72.1249","article-title":"Plasma resistin associated with myocardium injury in patients with acute coronary syndrome","volume":"72","author":"Chu","year":"2008","journal-title":"Circ J"},{"key":"10.1016\/j.det.2014.09.004_bib82","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/01.CIR.0000155620.10387.43","article-title":"Resistin is an inflammatory marker of atherosclerosis in humans","volume":"111","author":"Reilly","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.det.2014.09.004_bib83","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2133.2008.08655.x","article-title":"Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation","volume":"159","author":"Johnston","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib84","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/j.1365-2133.2007.08190.x","article-title":"Psoriasis patients show signs of insulin resistance","volume":"157","author":"Boehncke","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib85","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature03711","article-title":"Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes","volume":"436","author":"Yang","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.det.2014.09.004_bib86","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF00412490","article-title":"Psoriasis and vitamin A. Plasma transport and skin content of retinol, dehydroretinol and carotenoids in adult patients versus healthy controls","volume":"278","author":"Rollman","year":"1985","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.det.2014.09.004_bib87","doi-asserted-by":"crossref","first-page":"e000507","DOI":"10.1161\/JAHA.113.000507","article-title":"Endothelial cell-, platelet-, and monocyte\/macrophage-derived microparticles are elevated in psoriasis beyond cardiometabolic risk factors","volume":"3","author":"Takeshita","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.det.2014.09.004_bib88","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaad.2009.06.053","article-title":"Platelet activation in patients with psoriasis: increased plasma levels of platelet-derived microparticles and soluble P-selectin","volume":"62","author":"Tamagawa-Mineoka","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib89","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1038\/jid.2011.57","article-title":"Increased levels of circulating endothelial-derived microparticles and small-size platelet-derived microparticles in psoriasis","volume":"131","author":"Pelletier","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib90","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/CIRCRESAHA.110.237420","article-title":"Microparticles from human atherosclerotic plaques promote endothelial ICAM-1-dependent monocyte adhesion and transendothelial migration","volume":"108","author":"Rautou","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.det.2014.09.004_bib91","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/09537100802082249","article-title":"Platelet function in cutaneous diseases","volume":"19","author":"Kasperska-Zajac","year":"2008","journal-title":"Platelets"},{"key":"10.1016\/j.det.2014.09.004_bib92","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2340\/0001555565258262","article-title":"Increased platelet aggregation in psoriasis","volume":"65","author":"Hayashi","year":"1985","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.det.2014.09.004_bib93","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.0022-202X.2004.22318.x","article-title":"Activated, not resting, platelets increase leukocyte rolling in murine skin utilizing a distinct set of adhesion molecules","volume":"122","author":"Ludwig","year":"2004","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib94","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/PL00012428","article-title":"Elevated plasma levels of vascular endothelial growth factor and plasminogen activator inhibitor-1 decrease during improvement of psoriasis","volume":"51","author":"Nielsen","year":"2002","journal-title":"Inflamm Res"},{"key":"10.1016\/j.det.2014.09.004_bib95","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.amjcard.2008.10.004","article-title":"AJC editor's consensus: psoriasis and coronary artery disease","volume":"102","author":"Friedewald","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.det.2014.09.004_bib96","first-page":"305","article-title":"Psoriasis beyond the skin: an expert group consensus on the management of psoriatic arthritis and common co-morbidities in patients with moderate-to-severe psoriasis","author":"Strohal","year":"2014","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib97","doi-asserted-by":"crossref","first-page":"775.e1","DOI":"10.1016\/j.amjmed.2011.03.028","article-title":"Attributable risk estimate of severe psoriasis on major cardiovascular events","volume":"124","author":"Mehta","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.det.2014.09.004_bib98","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1381\/0960892041975569","article-title":"Psoriasis remission after laparoscopic Roux-en-Y gastric bypass for morbid obesity","volume":"14","author":"Higa-Sansone","year":"2004","journal-title":"Obes Surg"},{"key":"10.1016\/j.det.2014.09.004_bib99","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1365-2133.2005.06781.x","article-title":"Diet and psoriasis: experimental data and clinical evidence","volume":"153","author":"Wolters","year":"2005","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2014.09.004_bib100","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/bjd.12735","article-title":"Diet and physical exercise in psoriasis. A randomized trial","volume":"170","author":"Naldi","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib101","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3945\/ajcn.2008.26427","article-title":"Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial","volume":"88","author":"Gisondi","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.det.2014.09.004_bib102","doi-asserted-by":"crossref","first-page":"795932","DOI":"10.1155\/2013\/795932","article-title":"The effect of weight loss in obese patients with chronic stable plaque-type psoriasis","volume":"2013","author":"Roongpisuthipong","year":"2013","journal-title":"Dermatol Res Pract"},{"issue":"6","key":"10.1016\/j.det.2014.09.004_bib103","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jaad.2013.12.044","article-title":"Systemic treatment and narrowband ultraviolet B differentially affect cardiovascular risk markers in psoriasis","volume":"70","author":"Sigurdardottir","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2014.09.004_bib104","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/exd.12381","article-title":"Cardiovascular biomarkers in patients with psoriasis","volume":"23","author":"Gerdes","year":"2014","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib105","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.repc.2012.02.018","article-title":"High-sensitivity C-reactive protein as a biomarker of risk in coronary artery disease","volume":"31","author":"Silva","year":"2012","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.det.2014.09.004_bib106","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/rheumatology\/keq105","article-title":"Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis","volume":"49","author":"Chandran","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.det.2014.09.004_bib107","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1468-3083.2009.03527.x","article-title":"C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy","volume":"24","author":"Coimbra","year":"2010","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"9","key":"10.1016\/j.det.2014.09.004_bib108","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/echo.12511","article-title":"Neutrophil-to-lymphocyte ratio may predict subclinical atherosclerosis in patients with psoriasis","volume":"31","author":"Yurtda\u015f","year":"2014","journal-title":"Echocardiography"},{"key":"10.1016\/j.det.2014.09.004_bib109","first-page":"16","article-title":"Psoriasis and cardiovascular risk factors: increased serum myeloperoxidase and corresponding immunocellular overexpression by Cd11b(+) CD68(+) macrophages in skin lesions","volume":"6","author":"Cao","year":"2013","journal-title":"Am J Transl Res"},{"issue":"10","key":"10.1016\/j.det.2014.09.004_bib110","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1468-3083.2010.03947.x","article-title":"Effective continuous systemic therapy of severe plaque-type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: results of a prospective longitudinal observational study","volume":"25","author":"Boehncke","year":"2011","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2014.09.004_bib111","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1001\/archdermatol.2012.2502","article-title":"Association between tumor necrosis factor inhibitor therapy and myocardial infarction risk in patients with psoriasis","volume":"148","author":"Wu","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib112","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jaad.2004.06.017","article-title":"Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis","volume":"52","author":"Prodanovich","year":"2005","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib113","unstructured":"Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01594333?term=NCT01594333&rank=1. Accessed March 31, 2014."},{"key":"10.1016\/j.det.2014.09.004_bib114","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jaad.2010.02.062","article-title":"The use of cyclosporine in dermatology: part II","volume":"63","author":"Ryan","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib115","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jaad.2009.03.027","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents","volume":"61","author":"Menter","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib116","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S0190-9622(08)80257-5","article-title":"Long-term safety of retinoid therapy","volume":"27","author":"Vahlquist","year":"1992","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"Suppl 2","key":"10.1016\/j.det.2014.09.004_bib117","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1610-0387.2009.07059.x","article-title":"15 years of fumaderm: fumaric acid esters for the systemic treatment of moderately severe and severe psoriasis vulgaris","volume":"7","author":"Mrowietz","year":"2009","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"10.1016\/j.det.2014.09.004_bib118","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00403-010-1108-6","article-title":"Systemic therapy of plaque-type psoriasis ameliorates endothelial cell function: results of a prospective longitudinal pilot trial","volume":"303","author":"Boehncke","year":"2011","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.det.2014.09.004_bib119","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2796.2012.02593.x","article-title":"Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory0 drugs: a Danish real-world cohort study","volume":"273","author":"Ahlehoff","year":"2013","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.det.2014.09.004_bib120","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1365-2133.2008.08628.x","article-title":"Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis","volume":"159","author":"Strober","year":"2008","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.det.2014.09.004_bib121","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1365-2230.2011.04131.x","article-title":"The role of inflammatory markers in assessing disease severity and response to treatment in patients with psoriasis treated with etanercept","volume":"36","author":"Kanelleas","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib122","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1001\/jama.2011.878","article-title":"Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis","volume":"305","author":"Solomon","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.det.2014.09.004_bib123","first-page":"864","article-title":"Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials","volume":"306","author":"Ryan","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.det.2014.09.004_bib124","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1468-3083.2012.04500.x","article-title":"Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12\/23 biological agents for chronic plaque psoriasis: a meta-analysis of randomized controlled trials","volume":"27","author":"Tzellos","year":"2013","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2014.09.004_bib125","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jaad.2013.01.011","article-title":"Major cardiovascular events associated with anti-IL 12\/23 agents: a tale of two meta-analyses","volume":"68","author":"Dommasch","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2014.09.004_bib126","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/sim.4780090307","article-title":"Bias in the one-step method for pooling study results","volume":"9","author":"Greenland","year":"1990","journal-title":"Stat Med"},{"key":"10.1016\/j.det.2014.09.004_bib127","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/bjd.12214","article-title":"Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up","volume":"168","author":"Papp","year":"2013","journal-title":"Br J Dermatol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863514001107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863514001107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T15:13:14Z","timestamp":1747149194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863514001107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":127,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0733863514001107"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2014.09.004","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psoriasis Is a Systemic Disease with Multiple Cardiovascular and Metabolic Comorbidities","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2014.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}